Clinical Trial Update: Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating thymosin-alpha 1 as adjuvant treatment after radical resection for high-risk stage II and III colorectal cancer is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: Fudan University | Conditions: Stage II Colorectal Cancer, Stage III Colorectal Cancer | Phase 3 | Status: RECRUITING